Vol. 2, Issue - 3, Part A (2018)

Zuhair Kamal Kidwai

DOI: https://doi.org/10.33545/2616454X.2018.v2.i3a.51

Abstract:
Hyperuricemia is considered to be one of the leading causes of joint stiffness and pain especially small joint most commonly affecting first metatarsophalangeal joint. This is an excess of uric acid in the blood. It is commonly associated with traditional risk factors such as dysglicemia, dyslipidemia, central obesity, gout (Nikras), gouty arthritis, tophi formation, abnormal blood pressure, etc. Concordantly, recent studies have revived the controversy over the role of circulating uric acid, hyperuricemia, and gout (Nikras) as an independent prognostic factor. In this regard, the role of Unani compound medicine including Habb-e-Asgandh, Habb-e-Suranjan, and Sharbat Bazoori Motadil in combination with and without Hijama Bil-Shart (Wet Cupping), evaluated on multiple patients with the possibility of lowering increased serum uric acid level. In this review, we will focus on controlling of hyperuricemia with the use of Unani Medicine and Hijama Bil Shart.